CG Oncology
Likely to Engage tag.Highly Engaged Employees

Manufacturing · California, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

400 Spectrum Center Dr Ste 2040, Irvine,...

Phone Number

(949) 409-3700

Revenue

$5.1 Million

Stock Symbol

CGON

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
4
1
1
1
1
1

About CG Oncology

CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. At CG Oncology, we see a world where urologic cancer patients can benefit from their innovative immunotherapies to live with dignity and have an enhanced quality of life.Explore more
CG Oncology's Social MediaPopular SearchesCg Oncology IncCold Genesys IncCG OncologyCold GenesysOncology IncSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: CGONShow more

CG Oncology Org Chart

AK
United States flag for contact location.

Chairman & Chief Executive Officer

PhoneEmail
James DeTore, Chief Financial Officer at CG Oncology
United States flag for contact location.

Chief Financial Officer

PhoneEmail
Ambaw Bellete, President & Chief Operating Officer at CG Oncology
United States flag for contact location.

President & Chief Operating Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
ET
United States flag for contact location.

Director, Finance & Accounting

PhoneEmail
GP
United States flag for contact location.

Director, Financial Systems & Reporting

PhoneEmail
CA
United States flag for contact location.

Director, Technical Accounting & SEC Reportin...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is CG Oncology your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to CG Oncology

Compare insights from companies similar to CG Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

CG Oncology

$5.1M
51-200
Public
$697.6M
2010
AK
Arthur KuanChairman & CEO
$49.6M
51-200
Public
$599M
2010
John Hayslip, Chief Medical Officer at Verastem
John HayslipChief Medical Officer
$19M
51-200
Private
$95M
2016
Stephen Russell, Co-Founder & Chief Executive Officer at Vyriad
Stephen RussellCo-Founder & CEO
$18.8M
51-200
Private
$243.5M
2015
SS
Sam StraussManager, Human Resources
$14M
51-200
Private
$31.9M
1997
AG
Andrew GrahamTechnical Operations Vice President, Development
<$5M
51-200
Public
$406.5M
1998
51-200
Public
$195.4M
1999
PP
Paul PeterPresident & CEO
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

CG Oncology is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

CG Oncology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CG Oncology.

CG Oncology financials insights

Gather financial insights about CG Oncology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2014

Series A

$13.6M

2015

Series B

$10M

2019

Series C

$22M

2020

Series D

$47M

2022

Series E

$120M

2023

Other Financing Round

$105M

2024

Stock Offering

$380M

See All CG Oncology's Financials Insights

CG Oncology Tech Stack

A closer look at the technologies used by CG Oncology

Most Recent Scoops

Facilities Relocation / Expansion
CG Oncology has acquired a fill and finish site, with ongoing efforts to upgrade the facility to meet CBER inspection readiness standards, including the engagement of ex-FDA inspectors on a contract basis to prepare for inspection. The site has previously been inspected by CDRH with no Form 483 observations cited.
Facilities Relocation/Expansion
Project
CG Oncology has reported a 92% complete response rate in evaluable patients from the CORE-008 cohort CX study evaluating cretostimogene in combination with gemcitabine in BCG-exposed patients, compared to a 76% complete response rate observed with cretostimogene monotherapy in the BOND-003 study. Updated 12-month data from this cohort is expected to be reported later in the year.
Project
CG Oncology has announced plans to hire a field force of 50 to 75 sales representatives to support its upcoming commercial launch, consistent with the competitive landscape given the concentration of target accounts.
Project
CG Oncology has reported that cretostimogene achieved a complete response (CR) rate of approximately 76% at any time in the BCG-unresponsive carcinoma in situ (CIS) cohort, with a 12-month landmark CR rate of 46% and a 24-month landmark CR rate of 42%, with the median duration of response not yet met but exceeding 25 months. Additional data beyond 24 months is expected to be reported later in the year as the study continues through three years of follow-up.
Project
See more scoops

Top Manufacturing Companies

Frequently Asked Questions Regarding CG Oncology

What is CG Oncology's stock symbol?
CG Oncology's stock symbol is CGON
What is CG Oncology's official website?
CG Oncology's official website is www.cgoncology.com
What is CG Oncology's Revenue?
CG Oncology's revenue is $5.1 Million
What is CG Oncology's SIC code?
CG Oncology's SIC: 28,283
What is CG Oncology's NAICS code?
CG Oncology's NAICS: 32,325
How many employees does CG Oncology have?
CG Oncology has 51-200 employees
What industry does CG Oncology belong to?
CG Oncology is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is CG Oncology competition?
CG Oncology top competitors include: Northwest Biotherapeutics, Candel Therapeutics, AlphaVax, Oncorus
What technology does CG Oncology use?
Some of the popular technologies that CG Oncology uses are: DocuSign, WooCommerce, WordPress.org, PHP
Who is the CFO of CG Oncology?
CG Oncology's CFO is James DeTore
How do I contact CG Oncology?
CG Oncology contact info: Phone number: (949) 409-3700 Website: www.cgoncology.com
What does CG Oncology do?

CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. At CG Oncology, we see a world where urologic cancer patients can benefit from their innovative immunotherapies to live with dignity and have an enhance... d quality of life.Read More

What are CG Oncology social media links?
CG Oncology Linkedin page CG Oncology Twitter page
Who invested in CG Oncology?
CG Oncology has 22 investors including WI Harper Group, Ally Bridge Group, Whitesun Healthcare Ventures and Ally Bridge Group.
Is CG Oncology a public company?
Yes, CG Oncology is a public company and is traded under the symbol CGON
See more information about CG Oncology

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.